Arjo AB (publ)
Sweden · SE0010468116 · reports in SEK · Europe
Four figures
From the annual report for the year to Dec 31, 2025. Each line says what it is based on.
- Revenue growth
- Revenue −2.6% in the year to Dec 31, 2025, on the year before.
- Return on equity
- It earned 4.5% on its shareholders' equity in the year to Dec 31, 2025.
- Equity and assets
- No balance sheet tagged in the filing.
- Price and earnings
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2025, consolidated, in SEK.
revenue
operating margin
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|
| Revenue | SEK 10.0B | SEK 11.0B | SEK 11.3B | SEK 11.0B |
| Operating profit | SEK 691M | SEK 884M | SEK 893M | SEK 675M |
| Net profit to shareholders | SEK 447M | SEK 480M | SEK 498M | SEK 334M |
| Earnings per share | SEK 1.64 | SEK 1.76 | SEK 1.83 | SEK 1.23 |
| Dividend per share | SEK 1.15 | n/a | n/a | SEK 0.95 |
| Cash from operations | SEK 915M | SEK 2.1B | SEK 1.5B | SEK 1.4B |
| Capital spending | n/a | SEK 403M | SEK 393M | SEK 419M |
| Cash | SEK 949M | SEK 923M | SEK 892M | SEK 836M |
| Total assets | SEK 16.2B | SEK 15.4B | SEK 16.3B | SEK 15.0B |
What they do
In the company's own words, from the annual report.
Arjo är en global leverantör av medicintekniska produkter och lösningar som genom att skapa möjlighet för ökad mobilitet bidrar till bättre kliniska och finansiella resultat i vården och därmed till ett hållbart sjukvårdssystem. Verksamheten är till största delen förlagd utanför Sverige och Arjos största marknader är USA, Storbritannien, Frankrike, Kanada och Tyskland.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the ratios from the filed figures.